GT Biopharma, Inc. (GTBP) vs Tvardi Therapeutics, Inc. (TVRD)
- GT Biopharma, Inc. GTBP 7.03 −4.48%
- Tvardi Therapeutics, Inc. TVRD 1.01 −5.61%
GT Biopharma, Inc. and Tvardi Therapeutics, Inc. are both Biotechnology companies. GT Biopharma, Inc. and Tvardi Therapeutics, Inc. are of similar size ($15.2M and $14.3M). Tvardi Therapeutics, Inc. grew revenue faster over the last twelve months: −34.4% against −76.2%. Across the 13 metrics below, Tvardi Therapeutics, Inc. leads on 8 and GT Biopharma, Inc. on 5.
Valuation
Profitability
| Metric | GTBP | TVRD | Biotechnology median |
|---|---|---|---|
| Gross margin | 41.67% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 102.03% | (126.19%) | (56.36%) |
| Return on assets | (176.27%) | (85.08%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack